Antiviral therapy of HCV in the cirrhotic and transplant candidate
<p>Despite the improved efficacy of peginterferons, the rate of sustained virologic response is suboptimal in cirrhotic patients, relative to non-cirrhotic patients. However, the treatment of patients with compensated cirrhosis has recently been encouraged by expert panels. Interferon-based th...
Format: | Article |
---|---|
Language: | English |
Published: |
Ivyspring International Publisher
2006-04-01
|
Series: | International Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.medsci.org/v03p0075.htm |
Similar Items
-
Grading antiviral therapy in HCV-infected cirrhotic patients
by: ZHANG Ying
Published: (2013-02-01) -
Antiviral therapy in HCV-infected decompensated cirrhotics
by: Danish Fazal, et al.
Published: (2010-01-01) -
Antiviral therapy in patients with HCV-cirrhosis
by: Josep Melero, et al.
Published: (2009-10-01) -
Features of HCV recurrence in patients with HCV-related cirrhosis after liver transplantation and its antiviral and immunomodulatory therapies
by: JIAO Jian
Published: (2014-01-01) -
Antiviral therapy for recurrent hepatitis C after liver transplantation and its effect on liver fibrosis
by: ZHOU Shuangnan
Published: (2014-01-01)